Wells Fargo analyst Chris Carey lowered the firm’s price target on Clorox (CLX) to $145 from $155 and keeps an Equal Weight rating on the shares. The firm is refreshing its global sell-in/sell-through framework one last time before EPS kicks off next week. The final cut of U.S. data is likely to accelerate jitters on consumption, even as emerging market data felt a positive offset for multi-nationals.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CLX:
